Case Study: Syngenta achieves faster, more accurate screening with Reshape Biotech

How Syngenta digitally transformed detection of active compounds using AI

Syngenta, a global developer of high-quality seeds, faced the challenge of scaling up its high-throughput screening for active compounds. Their manual process was slow, subjective, and limited by scalability issues, creating a bottleneck in identifying new candidate trait leads. To address this, they partnered with vendor Reshape Biotech to implement the Reshape Biology Platform for a more automated and accurate solution.

The solution from Reshape Biotech used AI and high-resolution imaging to fully automate Syngenta's assay analysis. This implementation delivered a 400% increase in throughput, an 80% reduction in false negatives, and a 30% faster time-to-result. The Reshape platform also improved data objectivity and resolution, allowing Syngenta to extract greater insights from their existing assays and make better decisions faster.

Syngenta

Stuart Harrison

Head of Seeds R&D Partnerships and Open Innovation